Michel Seidelin Appointed Chief Commercial Officer as Biomatters Prepares to Release New Offerings

Auckland, New Zealand (PRWEB) June 04, 2015

CEO Brett Ammundsen says, “We are obviously very pleased that Michel joins us. His deep market expertise and understanding are an ideal complement to our team as we drive the next growth phase for Biomatters.”

“This is an exciting time to join Biomatters,” says Michel. “In addition to continuing our commitment to Geneious users, we are preparing to launch impressive new, cloud-based offerings that will secure our position as one of the leading bioinformatics focused companies.”

Michel’s appointment follows a record Geneious sales year. “We saw an almost 50% increase in Geneious sales, which speaks to the strength of our existing business model of continuously supporting the advances in biological research with great bioinformatics software,” says Michel. “Our customers simply love Geneious for its friendliness and easy access to premier bioinformatics tools.”

Biomatters has for a while prepared a world-class cloud-infrastructure to support the needs of the growing genomics industry. “Building on Biomatters’ more than decade long reputation of supporting researchers in their daily sequence informatics work, we look forward to supporting new markets with our directed solutions for interpretation of genomic data,” says Michel.

About Michel Seidelin

Michel has more than 15 years of experience with international management and business development in the genomics industry. Most recently he worked as the Vice President of Global Sales & Support at CLC bio.

About Biomatters

Biomatters was founded in 2003 with a mission to create bioinformatics solutions for the analysis, interpretation, and application of molecular sequence data. Headquartered in New Zealand with offices in the United States, and users in more than 100 countries worldwide, our solutions enhance productivity in over 3,000 universities, research institutes and companies.

Michel Seidelin is available for interview. Please contact;

Melissa Pentecost

Marketing and Communications Manager



Molecular biology

Leave a Reply